STRATHROY, ON, July 18, 2014 /CNW/ - For over 15 years Accucaps Industries Ltd., an innovation-based pharmaceutical contract development and manufacturing organization, has been a proud supplier to the life-saving vitamin A supplementation program for the Micronutrient Initiative and this year is no different.
High-strength vitamin A is essential for promoting good health. When vitamin A deficient children receive a twice-annual dose of vitamin A, child blindness is reduced by up to 70% and child mortality rates decrease by up to 24%. For this reason, high-strength vitamin A supplementation is recognized as one of the most cost-effective ways to improve child survival in the world's most vulnerable populations.
Over the years Accucaps has supplied over 4 billion vitamin A capsules to the Micronutrient Initiative. "Accucaps is grateful and proud to be an integral part of this Canadian success story that improves and saves the lives of millions of children around the world", according to Bruno Biscaro, Accucaps President.
Accucaps celebrated the inauguration of life-saving vitamin A capsule production this year with a ribbon-cutting ceremony on July 15, 2014 at their Strathroy, Ontario operation with Bev Shipley, M.P. Member of Parliament (Lambton-Kent-Middlesex) and Christina Dendys, Micronutrient Initiative Director, External Relations.
The Micronutrient Initiative is a global nutrition organization, headquartered in Ottawa, Ontario and is a leading organization working exclusively to eliminate vitamin and mineral deficiencies in the world´s most vulnerable populations. The Micronutrient Initiative reaches 500 million people every year with interventions to boost nutrition for the world´s most vulnerable, especially women and children. Through the Micronutrient Initiative and with support from the Government of Canada, the vitamin A supplementation program has supplied more than 8 billion vitamin A capsules through child health programs to help save the lives of more than 3 million children worldwide.
Accucaps is a wholly owned Canadian pharmaceutical contract development and manufacturing organization specializing in the soft gelatin dose form. Accucaps employs more than 500 people in Windsor and Strathroy, Ontario, with over 50 Scientists dedicated to developing and innovating new pharmaceutical products. Accucaps develops and produces products for many of the world's leading pharmaceutical, cosmetics, and health & nutritional companies.
Image with caption: "L to R: Martin Quesnel, Bev Shipley M.P., Colin McClintock, Eric Erickson & Brenda Brown, Scott McRorie, Christina Dendys, Bruno Biscaro, Tom Hawkeswood at the Accucaps vitamin A production kick-off ribbon cutting ceremony. (CNW Group/Accucaps Industries Limited)". Image available at: http://photos.newswire.ca/images/download/20140718_C8184_PHOTO_EN_42188.jpg
SOURCE: Accucaps Industries Limited
For further information:
Jackie DeMartin - HR Administrator, Communications
519-969-5404 ext. 3660